Polidocanol foam sclerotherapy
Sponsors
Universidade do Porto, Hospital Universitario Pedro Ernesto, Antonio Eduardo Zerati, University of Sao Paulo
Conditions
Bleeding DisorderChronic Venous DiseaseHemorrhoidsLiver CirrhosisReticular VeinsTelangiectasiasVaricose VeinsVaricose Veins of Leg With Long Saphenous Vein Distribution
Phase 2
Sclerotherapy With Polidocanol Foam In The Treatment Of Hemorrhoidal Disease In Patients With Bleeding Disorders
NCT04188171
Start: 2018-08-01End: 2021-02-01Target: 150Updated: 2020-08-19
Polidocanol Foam VS Artery Ligation in Hemorrhoidal Disease
CompletedNCT04675177
Start: 2019-09-01End: 2020-03-25Updated: 2021-02-10
Polidocanol Foam in Hemorrhoidal Disease in Patients With Liver Cirrhosis
NCT05807425
Start: 2023-03-31End: 2023-12-31Target: 40Updated: 2023-04-11
Phase 4
Mechanochemical Ablation Versus Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein
RecruitingNCT07561320
Start: 2026-05-01End: 2027-11-01Target: 50Updated: 2026-05-01
Foam Sclerotherapy With or Without Transdermal Laser for Reticular Veins and Telangiectasias
Active, not recruitingNCT07793630
Start: 2026-09-01End: 2027-05-01Target: 70Updated: 2026-09-03